Resultados da busca - S Arunachalam, Prabhu
- Mostrando 1 - 20 resultados de 23
- Ir para a próxima página
-
1
-
2
Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination por Arunachalam, Prabhu S., Mishra, Ria, Badarinath, Krithika, Selvam, Deepak, Payeli, Sravan K., Stout, Richard R., Ranga, Udaykumar
Publicado em 2016Texto -
3
A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice por Lee, Audrey, Scott, Madeleine K. D., Wimmers, Florian, Arunachalam, Prabhu S., Luo, Wei, Fox, Christopher B., Tomai, Mark, Khatri, Purvesh, Pulendran, Bali
Publicado em 2022Texto -
4
PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C por Sharma, Shilpee, Arunachalam, Prabhu S., Menon, Malini, Ragupathy, Viswanath, Satya, Ravi Vijaya, Jebaraj, Joshua, Aralaguppe, Shambhu Ganeshappa, Rao, Chaitra, Pal, Sreshtha, Saravanan, Shanmugam, Murugavel, Kailapuri G., Balakrishnan, Pachamuthu, Solomon, Suniti, Hewlett, Indira, Ranga, Udaykumar
Publicado em 2018Texto -
5
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection por Charles, Tysheena P., Burton, Samantha L., Arunachalam, Prabhu S., Cottrell, Christopher A., Sewall, Leigh M., Bollimpelli, Venkata S., Gangadhara, Sailaja, Dey, Antu K., Ward, Andrew B., Shaw, George M., Hunter, Eric, Amara, Rama R., Pulendran, Bali, van Gils, Marit J., Derdeyn, Cynthia A.
Publicado em 2021Texto -
6
Durability of immune responses to the BNT162b2 mRNA vaccine por Suthar, Mehul S., Arunachalam, Prabhu S., Hu, Mengyun, Reis, Noah, Trisal, Meera, Raeber, Olivia, Chinthrajah, Sharon, Davis-Gardner, Meredith E., Manning, Kelly, Mudvari, Prakriti, Boritz, Eli, Godbole, Sucheta, Henry, Amy R., Douek, Daniel C., Halfmann, Peter, Kawaoka, Yoshihiro, Boyd, Scott D., Davis, Mark M., Zarnitsyna, Veronika I., Nadeau, Kari, Pulendran, Bali
Publicado em 2022Texto -
7
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19 por Hu, Zicheng, van der Ploeg, Kattria, Chakraborty, Saborni, Arunachalam, Prabhu, Mori, Diego, Jacobson, Karen, Bonilla, Hector, Parsonnet, Julie, Andrews, Jason, Hedlin, Haley, de la Parte, Lauren, Dantzler, Kathleen, Ty, Maureen, Tan, Gene, Blish, Catherine, Takahashi, Saki, Rodriguez-Barraquer, Isabel, Greenhouse, Bryan, Butte, Atul, Singh, Upinder, Pulendran, Bali, Wang, Taia, Jagannathan, Prasanna
Publicado em 2022Texto -
8
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition por Röltgen, Katharina, Nielsen, Sandra C. A., Arunachalam, Prabhu S., Yang, Fan, Hoh, Ramona A., Wirz, Oliver F., Lee, Alexandra S., Gao, Fei, Mallajosyula, Vamsee, Li, Chunfeng, Haraguchi, Emily, Shoura, Massa J., Wilbur, James L., Wohlstadter, Jacob N., Davis, Mark M., Pinsky, Benjamin A., Sigal, George B., Pulendran, Bali, Nadeau, Kari C., Boyd, Scott D.
Publicado em 2021Texto -
9
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non... por Pillet, Stéphane, Arunachalam, Prabhu S., Andreani, Guadalupe, Golden, Nadia, Fontenot, Jane, Aye, Pyone Pyone, Röltgen, Katharina, Lehmicke, Gabrielle, Gobeil, Philipe, Dubé, Charlotte, Trépanier, Sonia, Charland, Nathalie, D’Aoust, Marc-André, Russell-Lodrigue, Kasi, Monjure, Christopher, Blair, Robert V., Boyd, Scott D., Bohm, Rudolf P., Rappaport, Jay, Villinger, François, Landry, Nathalie, Pulendran, Bali, Ward, Brian J.
Publicado em 2022Texto -
10
Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses por Sievers, Benjamin L., Chakraborty, Saborni, Xue, Yong, Gelbart, Terri, Gonzalez, Joseph C., Cassidy, Arianna G., Golan, Yarden, Prahl, Mary, Gaw, Stephanie L., Arunachalam, Prabhu S., Blish, Catherine A., Boyd, Scott D., Davis, Mark M., Jagannathan, Prasanna, Nadeau, Kari C., Pulendran, Bali, Singh, Upinder, Scheuermann, Richard H., Frieman, Matthew B., Vashee, Sanjay, Wang, Taia T., Tan, Gene S.
Publicado em 2022Texto -
11
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine por Li, Chunfeng, Lee, Audrey, Grigoryan, Lilit, Arunachalam, Prabhu S., Scott, Madeleine K. D., Trisal, Meera, Wimmers, Florian, Sanyal, Mrinmoy, Weidenbacher, Payton A., Feng, Yupeng, Adamska, Julia Z., Valore, Erika, Wang, Yanli, Verma, Rohit, Reis, Noah, Dunham, Diane, O’Hara, Ruth, Park, Helen, Luo, Wei, Gitlin, Alexander D., Kim, Peter, Khatri, Purvesh, Nadeau, Kari C., Pulendran, Bali
Publicado em 2022Texto -
12
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice por Grigoryan, Lilit, Lee, Audrey, Walls, Alexandra C., Lai, Lilin, Franco, Benjamin, Arunachalam, Prabhu S., Feng, Yupeng, Luo, Wei, Vanderheiden, Abigail, Floyd, Katharine, Wrenn, Samuel, Pettie, Deleah, Miranda, Marcos C., Kepl, Elizabeth, Ravichandran, Rashmi, Sydeman, Claire, Brunette, Natalie, Murphy, Michael, Fiala, Brooke, Carter, Lauren, Coffman, Robert L., Novack, David, Kleanthous, Harry, O’Hagan, Derek T., van der Most, Robbert, McLellan, Jason S., Suthar, Mehul, Veesler, David, King, Neil P., Pulendran, Bali
Publicado em 2022Texto -
13
Systems biological assessment of human immunity to BNT162b2 mRNA vaccination por Arunachalam, Prabhu S., Scott, Madeleine K. D., Hagan, Thomas, Li, Chunfeng, Feng, Yupeng, Wimmers, Florian, Grigoryan, Lilit, Trisal, Meera, Edara, Venkata Viswanadh, Lai, Lilin, Chang, Sarah Esther, Feng, Allan, Dhingra, Shaurya, Shah, Mihir, Lee, Allie Skye, Chinthrajah, Sharon, Sindher, Tina, Mallajosyula, Vamsee, Gao, Fei, Sigal, Natalia, Kowli, Sangeeta, Gupta, Sheena, Pellegrini, Kathryn, Tharp, Gregory, Maysel-Auslender, Sofia, Bosinger, Steven, Maecker, Holden T., Boyd, Scott D., Davis, Mark M., Utz, Paul J., Suthar, Mehul S., Khatri, Purvesh, Nadeau, Kari C., Pulendran, Bali
Publicado em 2021Texto -
14
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans por Arunachalam, Prabhu S., Wimmers, Florian, Mok, Chris Ka Pun, Perera, Ranawaka A. P. M., Scott, Madeleine, Hagan, Thomas, Sigal, Natalia, Feng, Yupeng, Bristow, Laurel, Tak-Yin Tsang, Owen, Wagh, Dhananjay, Coller, John, Pellegrini, Kathryn L., Kazmin, Dmitri, Alaaeddine, Ghina, Leung, Wai Shing, Chan, Jacky Man Chun, Chik, Thomas Shiu Hong, Choi, Chris Yau Chung, Huerta, Christopher, Paine McCullough, Michele, Lv, Huibin, Anderson, Evan, Edupuganti, Srilatha, Upadhyay, Amit A., Bosinger, Steve E., Maecker, Holden Terry, Khatri, Purvesh, Rouphael, Nadine, Peiris, Malik, Pulendran, Bali
Publicado em 2020Texto -
15
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers por Arunachalam, Prabhu S., Charles, Tysheena P., Joag, Vineet, Bollimpelli, Venkata S., Scott, Madeleine K. D., Wimmers, Florian, Burton, Samantha L., Labranche, Celia C., Petitdemange, Caroline, Gangadhara, Sailaja, Styles, Tiffany M., Quarnstrom, Clare F., Walter, Korey A., Ketas, Thomas J., Legere, Traci, Jagadeesh Reddy, Pradeep Babu, Kasturi, Sudhir Pai, Tsai, Anthony, Yeung, Bertrand Z., Gupta, Shakti, Tomai, Mark, Vasilakos, John, Shaw, George M., Kang, Chil-Yong, Moore, John P., Subramaniam, Shankar, Khatri, Purvesh, Montefiori, David, Kozlowski, Pamela A., Derdeyn, Cynthia A., Hunter, Eric, Masopust, David, Amara, Rama R., Pulendran, Bali
Publicado em 2020Texto -
16
Systems vaccinology of the BNT162b2 mRNA vaccine in humans por Arunachalam, Prabhu S., Scott, Madeleine K. D., Hagan, Thomas, Li, Chunfeng, Feng, Yupeng, Wimmers, Florian, Grigoryan, Lilit, Trisal, Meera, Edara, Venkata Viswanadh, Lai, Lilin, Chang, Sarah Esther, Feng, Allan, Dhingra, Shaurya, Shah, Mihir, Lee, Alexandra S., Chinthrajah, Sharon, Sindher, Sayantani B., Mallajosyula, Vamsee, Gao, Fei, Sigal, Natalia, Kowli, Sangeeta, Gupta, Sheena, Pellegrini, Kathryn, Tharp, Gregory, Maysel-Auslender, Sofia, Hamilton, Sydney, Aoued, Hadj, Hrusovsky, Kevin, Roskey, Mark, Bosinger, Steven E., Maecker, Holden T., Boyd, Scott D., Davis, Mark M., Utz, Paul J., Suthar, Mehul S., Khatri, Purvesh, Nadeau, Kari C., Pulendran, Bali
Publicado em 2021Texto -
17
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia por Dashdorj, Naranjargal J., Wirz, Oliver F., Röltgen, Katharina, Haraguchi, Emily, Buzzanco, Anthony S., Sibai, Mamdouh, Wang, Hannah, Miller, Jacob A., Solis, Daniel, Sahoo, Malaya K., Arunachalam, Prabhu S., Lee, Alexandra S., Shah, Mihir M., Liu, James, Byambabaatar, Sumiya, Bat-Ulzii, Purevjargal, Enkhbat, Anir, Batbold, Enkhtuul, Zulkhuu, Delgersaikhan, Ochirsum, Byambasuren, Khurelsukh, Tungalag, Dalantai, Ganbold, Burged, Natsagdorj, Baatarsuren, Uurtsaikh, Ariungerel, Nomin, Oidovsambuu, Odgerel, Bungert, Andreas S., Genden, Zulkhuu, Yagaanbuyant, Dahgwahdorj, Mordorj, Altankhuu, Pulendran, Bali, Chinthrajah, Sharon, Nadeau, Kari C., Jardetzky, Theodore, Wilbur, James L., Wohlstadter, Jacob N., Sigal, George B., Pinsky, Benjamin A., Boyd, Scott D., Dashdorj, Naranbaatar D.
Publicado em 2021Texto -
18
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines por Walls, Alexandra C., Miranda, Marcos C., Pham, Minh N., Schäfer, Alexandra, Greaney, Allison, Arunachalam, Prabhu S., Navarro, Mary-Jane, Tortorici, M. Alejandra, Rogers, Kenneth, O’Connor, Megan A., Shireff, Lisa, Ferrell, Douglas E., Brunette, Natalie, Kepl, Elizabeth, Bowen, John, Zepeda, Samantha K., Starr, Tyler, Hsieh, Ching-Lin, Fiala, Brooke, Wrenn, Samuel, Pettie, Deleah, Sydeman, Claire, Johnson, Max, Blackstone, Alyssa, Ravichandran, Rashmi, Ogohara, Cassandra, Carter, Lauren, Tilles, Sasha W., Rappuoli, Rino, O’Hagan, Derek T., Van Der Most, Robbert, Van Voorhis, Wesley C., McLellan, Jason S., Kleanthous, Harry, Sheahan, Timothy P., Fuller, Deborah H., Villinger, Francois, Bloom, Jesse, Pulendran, Bali, Baric, Ralph, King, Neil, Veesler, David
Publicado em 2021Texto -
19
Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response por Chakraborty, Saborni, Gonzalez, Joseph C., Sievers, Benjamin L., Mallajosyula, Vamsee, Chakraborty, Srijoni, Dubey, Megha, Ashraf, Usama, Cheng, Bowie Yik-Ling, Kathale, Nimish, Tran, Kim Quyen Thi, Scallan, Courtney, Sinnott, Aanika, Cassidy, Arianna, Chen, Steven T., Gelbart, Terri, Gao, Fei, Golan, Yarden, Ji, Xuhuai, Kim-Schulze, Seunghee, Prahl, Mary, Gaw, Stephanie L., Gnjatic, Sacha, Marron, Thomas U., Merad, Miriam, Arunachalam, Prabhu S., Boyd, Scott D., Davis, Mark M., Holubar, Marisa, Khosla, Chaitan, Maecker, Holden T., Maldonado, Yvonne, Mellins, Elizabeth D., Nadeau, Kari C., Pulendran, Bali, Singh, Upinder, Subramanian, Aruna, Utz, Paul J., Sherwood, Robert, Zhang, Sheng, Jagannathan, Prasanna, Tan, Gene S., Wang, Taia T.
Publicado em 2021Texto -
20
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity por Chakraborty, Saborni, Gonzalez, Joseph C., Sievers, Benjamin L., Mallajosyula, Vamsee, Chakraborty, Srijoni, Dubey, Megha, Ashraf, Usama, Cheng, Bowie Yik-Ling, Kathale, Nimish, Tran, Kim Quyen Thi, Scallan, Courtney, Sinnott, Aanika, Cassidy, Arianna, Chen, Steven T., Gelbart, Terri, Gao, Fei, Golan, Yarden, Ji, Xuhuai, Kim-Schulze, Seunghee, Prahl, Mary, Gaw, Stephanie L., Gnjatic, Sacha, Marron, Thomas U., Merad, Miriam, Arunachalam, Prabhu S., Boyd, Scott D., Davis, Mark M., Holubar, Marisa, Khosla, Chaitan, Maecker, Holden T., Maldonado, Yvonne, Mellins, Elizabeth D., Nadeau, Kari C., Pulendran, Bali, Singh, Upinder, Subramanian, Aruna, Utz, Paul J., Sherwood, Robert, Zhang, Sheng, Jagannathan, Prasanna, Tan, Gene S., Wang, Taia T.
Publicado em 2022Texto